Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction

Cancer Biology and Therapy

Volumn 8, Issue 9, 2009, Pages 801-807

  Tahara, Eiji ^a   Kadara, Humam ^a   Lacroix, Ludovic ^a   Lotan, Dafna ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell cycle; KLF6; Lung cancer; NSCLC; p21WAF1 CIP1; PKC; PMA

Indexed keywords

BRYOSTATIN 1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; KRUPPEL LIKE FACTOR 6; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TOXIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; PRECANCER; UPREGULATION;

EID: 68149167955     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.9.8186     Document Type: Article

References (29)

1. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007; 7:281-94.
2. Clemens MJ, Trayner I, Menaya J. The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J Cell Sci 1992; 103:881-7.
3. Hofmann J. Protein kinase C isozymes as potential targets for anticancer therapy. Curr Cancer Drug Targets 2004; 4:125-46.
4. Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233:305-12.
5. 1 cell cycle checkpoint induced by the suppression of protein kinase C alpha and theta isoforms. J Biol Chem 2003; 278:39782-93.
6. Detjen KM, Brembeck FH, Welzel M, Kaiser A, Haller H, Wiedenmann B, et al. Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. J Cell Sci 2000; 113:3025-35.
7. Fujii T, Nakamura AM, Yokoyama G, Yamaguchi M, Tayama K, Miwa K, et al. Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells. Oncol Rep 2005; 14:489-94.
8. cip1 induction in HC11 mammary epithelial cells. Oncogene 1999; 18:6658-66.
9. Dale IL, Bradshaw TD, Gescher A, Pettit GR. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Cancer Res 1989; 49:3242-5.
10. Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res 1992; 52:1278-83.
11. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001; 188:143-60.
12. Kojima S, Hayashi S, Shimokado K, Suzuki Y, Shimada J, Crippa MP, et al. Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGFbeta1 in vascular endothelial cells. Blood 2000; 95:1309-16.
13. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001; 294:2563-6.
14. Ito G, Uchiyama M, Kondo M, Mori S, Usami N, Maeda O, et al. Kruppel-like factor 6 is frequently downregulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 2004; 64:3838-43.
15. Kimmelman AC, Qiao RF, Narla G, Banno A, Lau N, Bos PD, et al. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6. Oncogene 2004; 23:5077-83.
16. Kremer-Tal S, Reeves HL, Narla G, Thung SN, Schwartz M, Difeo A, et al. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 2004; 40:1047-52.
17. Lievre A, Landi B, Cote JF, Veyrie N, Zucman-Rossi J, Berger A, et al. Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers. Oncogene 2005; 24:7253-6.
18. Klein-Szanto AJ, Iizasa T, Momiki S, Garcia-Palazzo I, Caamano J, Metcalf R, et al. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc Natl Acad Sci USA 1992; 89:6693-7.
19. 1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 2005; 280:33926-34.
20. Oliva JL, Caino MC, Senderowicz AM, Kazanietz MG. S-Phase-specific activation of PKCalpha induces senescence in non-small cell lung cancer cells. J Biol Chem 2008; 283:5466-76.
21. Teixeira MS, Camacho-Vanegas O, Fernandez Y, Narla G, DiFeo A, Lee B, et al. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma. Int J Cancer 2007; 121:1976-83.
22. Camacho-Vanegas O, Narla G, Teixeira MS, DiFeo A, Misra A, Singh G, et al. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma. Int J Cancer 2007; 121:1390-5.
23. Yea S, Narla G, Zhao X, Garg R, Tal-Kremer S, Hod E, et al. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma. Gastroenterology 2008; 134:1521-31.
24. DiFeo A, Feld L, Rodriguez E, Wang C, Beer DG, Martignetti JA, et al. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res 2008; 68:965-70.
25. Bhisey RA, Sirsat SM. Selective promoting activity of phorbol myristate acetate in experimental skin carcinogenesis. Br J Cancer 1976; 34:661-5.
26. Van Duuren BL, Sivak A, Katz C, Seidman I, Melchionne S. The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res 1975; 35:502-5.
27. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994; 9:3397-406.
28. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/ CIP1 by a p53-independent pathway. Cancer Res 1994; 54:3391-5.
29. Park JW, Jang MA, Lee YH, Passaniti A, Kwon TK. p53-independent elevation of p21 expression by PMA results from PKC-mediated mRNA stabilization. Biochem Biophys Res Commun 2001; 280:244-8.